文献速递乳腺癌

东西方乳腺癌差异洞察:综述

Insights Into Breast Cancer in the East vs the West: A Review.
PubMed 文献 · JAMA Oncol · 2019-01-01

过去几十年东亚乳腺癌发病率快速上升,已成为多国最常见癌症。该综述比较东西方乳腺癌在流行病学、肿瘤与宿主生物学、遗传变异、药物耐受性及表型特征等方面的差异,指出亚洲人群前绝经期乳腺癌比例更高、免疫微环境更活跃、药物基因组差异影响耐受性,建议将更多亚洲女性纳入临床试验和流行病学及转化研究。

要点

  • 亚洲乳腺癌前绝经期比例较高,可能为年龄队列效应。
  • 东西方免疫组化亚型相对频率可能相似,亚洲管腔B亚型伴TP53突变更常见可能受早期检测差异混杂。
  • 亚洲乳腺癌微环境免疫活性更高,种系突变谱和单核苷酸多态性随种族而异。

核心结论

  • 乳腺癌已成为亚洲重大健康问题,将更多亚洲女性纳入临床试验和流行病学及转化研究有助于揭示种族间异质性及环境与内在因素的复杂交互,从而在种族多样性背景下优化预防、诊断和管理策略。

研究设计与样本

  • 综述,检索并汇总东西方乳腺癌在流行病学、肿瘤与宿主生物学、遗传变异、药物耐受性及表型特征等方面的已发表研究数据。

主要发现

  • 东亚乳腺癌发病率过去几十年快速上升,目前为多国最常见癌症,可能与生活方式和环境因素改变以及乳腺癌意识和筛查带来的早期诊断增加有关。
  • 亚洲前绝经期乳腺癌比例更高,但该因素可能是年龄队列效应。
  • 东西方不同免疫组化亚型相对频率可能相似,但亚洲管腔B亚型伴TP53突变更常见可能受早期检测差异混杂。
  • 亚洲乳腺癌似乎具有更免疫活跃的微环境,乳腺癌易感基因种系突变谱和单核苷酸多态性随种族而异。
  • 某些细胞毒和靶向药物耐受性差异可能与药物基因组因素相关,东亚女性平均体重较低可能导致固定剂量给药时毒性更高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: During the past few decades, the incidence of breast cancer (BC) has been increasing rapidly in East Asia, and BC is currently the most common cancer in several countries. The rising incidence is likely related to changing lifestyle and environmental factors in addition to the increase in early diagnosis with BC awareness and screening. The understanding and management of BC are generally based on research and data from the West. However, emerging differences in BC epidemiology and tumor and host biology in Asian populations may be clinically relevant. OBSERVATIONS: A higher proportion of premenopausal BCs occur in Asia, although this factor is possibly an age-cohort effect. Although the relative frequencies of different immunohistochemical subtypes of BC may be similar between the East and West, the higher prevalence of luminal B subtypes with more frequent mutations in TP53 may be confounded by disparities in early detection. In addition, Asian BCs appear to harbor a more immune-active microenvironment than BCs in the West. The spectra of germline mutations in BC predisposition genes and single-nucleotide polymorphisms contributing to BC risk vary with ethnicity as well. Differences in tolerability of certain cytotoxic and targeted agents used in BC treatment may be associated with pharmacogenomic factors, whereas the lower body mass of the average woman in East Asia may contribute to higher toxicities from drugs administered at fixed doses. Phenotypic characteristics, such as lower breast volume, may influence the type of surgery performed in East Asian women. On the other hand, increased breast density may affect the sensitivity of mammography in detecting BCs, limiting the benefits of screening mammography. CONCLUSIONS AND RELEVANCE: Breast cancer has become a major health problem in Asia. The inclusion of more women from Asia in clinical trials and epidemiologic and translational studies may help unravel the interethnic heterogeneity of BCs and elucidate the complex interplay between environmental and intrinsic factors in its pathogenesis. These insights may help to refine prevention, diagnosis, and management strategies for BC in the setting of ethnic diversity.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Yap YS, Lu YS, Tamura K, et al. Insights Into Breast Cancer in the East vs the West: A Review. JAMA Oncol. 2019. PMID: 31095268. doi:10.1001/jamaoncol.2019.0620

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。